T39.312
Poisoning by propionic acid derivatives, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by propionic acid derivatives, classified under ICD-10 code T39.312, refers to cases where individuals intentionally ingest or are exposed to this class of medication with the intent to harm themselves. Propionic acid derivatives include common anti-inflammatory drugs like ibuprofen and naproxen. While these medications are widely used for pain relief and inflammation reduction, their misuse or overdose can lead to serious health complications, especially when taken intentionally as a form of self-harm. Recognizing the causes, symptoms, and treatment options is important for health professionals and caregivers.
Causes & Symptoms
Clinical Causes: Intentional self-harm or suicide attempts involving ingestion of propionic acid derivative medications Misuse or overdose of over-the-counter medications containing propionic acid derivatives Lack of proper medication management or mental health support leading to deliberate poisoning Accidental ingestion in individuals with access to these medications without appropriate safeguards
Key Symptoms: Gastrointestinal discomfort such as nausea, vomiting, or abdominal pain Dizziness or lightheadedness Respiratory difficulties or irregular breathing patterns Signs of gastrointestinal bleeding, such as black or tarry stools Confusion or altered mental status Signs of metabolic disturbances like dehydration or electrolyte imbalance Seizures in severe overdose cases Potential kidney or liver dysfunction
Diagnostic & Treatment
Diagnosis Path: The diagnosis of poisoning caused by propionic acid derivatives involves a combination of medical history assessment, physical examination, and laboratory tests. Key diagnostic steps include: - Medical history review to determine the amount and time of ingestion - Blood tests to measure medication levels, kidney function, liver function, and electrolyte status - Urinalysis to detect the presence of drug metabolites - Monitoring for symptoms of toxicity or organ impairment In some scenarios, additional imaging or specific biochemical tests may be necessary to evaluate organ damage or complications arising from poisoning.
Treatment Protocols: Managing poisoning by propionic acid derivatives generally requires prompt medical intervention aimed at reducing drug absorption, supporting vital functions, and preventing complications. Typical treatment approaches include: - Administration of activated charcoal to limit absorption if the ingestion was recent - Intravenous fluids to maintain hydration and electrolyte balance - Medications to counteract specific symptoms, such as antiemetics for nausea or medications to stabilize heart rhythm - Regular monitoring of vital signs and laboratory parameters - In severe cases, hospitalization in an intensive care setting may be necessary - Supportive care for organ functions, including dialysis if kidney failure occurs - Mental health assessment and support to address underlying issues contributing to self-harm It’s essential that treatment be administered early and under medical supervision to improve outcomes and reduce risks of severe complications.
Clinical Advice & FAQs
Billing Guidance
Is T39.312 a billable ICD-10 code?
Yes, T39.312 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T39.312?
Clinical documentation must specify the nature of Poisoning by propionic acid derivatives, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
